MktsMarkets

Instil Bio, Inc.
NASDAQ: TILKey statistics
TIL News
Stories mentioning TIL from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | ||||||||
| Cost of Goods Sold | ||||||||
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | ||||||||
| Research & Development | 2,921 | |||||||
| Sales General & Admin | ||||||||
| Total Operating Expenses | 7,010 | 9,557 | 15,022 | 23,440 | 30,562 | 11,820 | 23,631 | 14,135 |
| Operating Income (Loss) | (7,010) | (9,557) | (15,022) | (23,440) | (30,562) | (11,820) | (23,631) | (14,135) |
| Interest Income | ||||||||
| Interest Expense | ||||||||
| Other Expense | (182.00) | 43.00 | ||||||
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (4,204) | (8,191) | (13,587) | (21,394) | (28,200) | (11,895) | (23,021) | (14,917) |
| Earnings Per Share (Basic) | (0.62) | (1.23) | (2.01) | (3.24) | (4.32) | (1.83) | (3.54) | (2.29) |
| Earnings Per Share (Diluted) | (0.62) | (1.23) | (2.01) | (3.24) | (4.32) | (1.83) | (3.54) | (2.29) |
| Weighted Average Shares Outstanding (Basic) | 6,782 | 6,668 | 6,758 | 6,597 | 6,533 | 6,510 | 6,507 | 6,504 |
| Weighted Average Shares Outstanding (Diluted) | 6,782 | 6,668 | 6,758 | 6,597 | 6,533 | 6,510 | 6,507 | 6,504 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About TIL
Instil Bio, Inc. (NASDAQ: TIL) is a stock listed on the Nasdaq Stock Market under the ticker symbol TIL. It last traded at $5.75 (Nov 16, 2026, 4:00 PM ET), down 5.4% on the day. That gives Instil Bio a market capitalisation of $39.0M.
Over the past 52 weeks TIL has traded between $5.56 and $15.23.
For the quarter ended Mar 31, 2026 it reported a net loss of $4.2M.
| Quarter ended | Revenue | Net income |
|---|---|---|
| Mar 31, 2026 | — | -$4.2M |
| Dec 31, 2025 | — | -$8.2M |
| Sep 30, 2025 | — | -$13.6M |
| Jun 30, 2025 | — | -$21.4M |
From Instil Bio’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…